Endocyte Inc. Stock
Your prediction
Pros and Cons of Endocyte Inc. in the next few years
Pros
?
S********** s********
?
W********* I********* f** t** n*** y****
?
B****
Cons
?
C******** o* t** e**********
?
G***** c******* t* c**********
?
M***** P*******
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Endocyte Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Endocyte Inc. | - | - | - | - | - | - | - |
| Ardelyx Inc. | 20.070% | 22.231% | 18.703% | 16.087% | 22.231% | 122.288% | 11.765% |
| Evolus Inc | 0.000% | -13.394% | -17.193% | -52.800% | -13.394% | -35.782% | 53.947% |
| Champions Oncology Inc | -0.910% | -6.034% | 9.000% | 14.496% | -6.034% | 36.250% | -39.444% |